• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[当A不再是A:血型分型的问题与陷阱]

[When A is not A anymore: problems and pitfalls with blood group typing].

作者信息

Möhnle P, Humpe A, Wittmann G

机构信息

Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie, Klinik für Anaesthesiologie, Universität München (LMU), Marchioninistr. 15, 81377, München, Deutschland.

出版信息

Anaesthesist. 2018 Sep;67(9):637-646. doi: 10.1007/s00101-018-0483-9.

DOI:10.1007/s00101-018-0483-9
PMID:30171285
Abstract

Correct blood group typing is a prerequisite for transfusion. In most cases blood group determination is without problems; however, in individual cases various factors can complicate blood group determination and sometimes lead to confusing findings. For a better understanding the clinician should have basic knowledge of blood typing. Blood group determination usually covers the AB0 blood groups, Rhesus and Kell systems; in addition, a direct Coombs test and an antibody screening test for the detection of irregular antibodies in the recipient are performed. Confusion of patients, blood samples, results or preparations can lead to severe consequences due to incompatible transfusion and must be prevented. In this context, bedside blood type testing before transfusion is of utmost importance. Problems in laboratory analysis as well as patient-related factors, such as the existence of irregular antibodies against red blood cells can complicate the immunohematology diagnostics. Certain medications, such as daratumumab, lead to a significantly increased complexity in laboratory analyses. Massive transfusions can lead to chimerism with more than one population of circulating red blood cells. Hematopoetic stem cell transplantation can also lead to a change in blood groups as well as chimerism. In addition, there are various other rare causes that can result in difficulties in blood group determination, such as rare blood groups or rare disease-associated phenomena. In the case of problems in blood group determination, early and close cooperation with transfusion medicine is essential for the clinician.

摘要

正确的血型鉴定是输血的前提条件。在大多数情况下,血型鉴定并无问题;然而,在个别情况下,多种因素会使血型鉴定变得复杂,有时还会导致令人困惑的结果。为了更好地理解,临床医生应具备血型鉴定的基础知识。血型鉴定通常涵盖AB0血型、恒河猴血型和凯尔血型系统;此外,还会进行直接抗人球蛋白试验和抗体筛查试验,以检测受血者体内的不规则抗体。由于输血不相容,患者、血样、结果或制剂的混淆可能导致严重后果,必须加以预防。在此背景下,输血前的床边血型检测至关重要。实验室分析中的问题以及与患者相关的因素,如存在针对红细胞的不规则抗体,会使免疫血液学诊断变得复杂。某些药物,如达雷妥尤单抗,会导致实验室分析的复杂性显著增加。大量输血可导致出现具有不止一种循环红细胞群体的嵌合体。造血干细胞移植也可导致血型改变以及嵌合体的出现。此外,还有各种其他罕见原因可导致血型鉴定困难,如罕见血型或与罕见疾病相关的现象。在血型鉴定出现问题的情况下,临床医生与输血医学尽早并密切合作至关重要。

相似文献

1
[When A is not A anymore: problems and pitfalls with blood group typing].[当A不再是A:血型分型的问题与陷阱]
Anaesthesist. 2018 Sep;67(9):637-646. doi: 10.1007/s00101-018-0483-9.
2
Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.巴基斯坦定期输血的β地中海贫血患者中的红细胞同种免疫
Transfus Med. 2015 Apr;25(2):106-10. doi: 10.1111/tme.12196. Epub 2015 Apr 14.
3
Transfusion Medicine: An Update on Antigens, Antibodies and Serologic Testing in Dogs and Cats.输血医学:犬猫抗原、抗体及血清学检测的最新进展
Top Companion Anim Med. 2019 Mar;34:36-46. doi: 10.1053/j.tcam.2018.12.005. Epub 2018 Dec 31.
4
[Immunohematologic study and transfusion approach to patients with public antibodies].[公共抗体患者的免疫血液学研究及输血方法]
Sangre (Barc). 1997 Feb;42(1):25-9.
5
[Interpretation of the results of immunohematological tests in hematological patients.].
Klin Lab Diagn. 2019;64(4):221-224. doi: 10.18821/0869-2084-2019-64-4-221-224.
6
Medicolegal assessment of blood transfusion errors--an interdisciplinary challenge.输血错误的法医学评估——一项跨学科挑战。
Forensic Sci Int. 2007 Oct 2;172(1):40-8. doi: 10.1016/j.forsciint.2006.12.001. Epub 2007 Jan 12.
7
[Analysis of irregular antibodies in the department of transfusion medicine 1984-1988].[1984 - 1988年输血医学科不规则抗体分析]
Beitr Infusionsther. 1990;26:415-9.
8
[Irregular erythrocytic antibodies as an obstacle to transfusion].[不规则红细胞抗体作为输血的障碍]
Z Arztl Fortbild (Jena). 1984;78(20):849-52.
9
[Immunological safety in blood transfusion. Current practical rules (author's transl)].[输血中的免疫安全性。现行实用规则(作者译)]
Anesth Analg (Paris). 1981;38(11-12):679-83.
10
[Transfusion management of patients with red blood cell antibodies].[红细胞抗体患者的输血管理]
Med Pregl. 2013 Nov-Dec;66(11-12):491-6. doi: 10.2298/mpns1312491b.

引用本文的文献

1
The development of a legal framework for blood donation and blood safety in China over 24 years.24年来中国献血与血液安全法律框架的发展
BMC Health Serv Res. 2020 Nov 30;20(1):1099. doi: 10.1186/s12913-020-05944-6.
2
[The patient blood group-the small but important difference].[患者血型——微小却重要的差异]
Anaesthesist. 2018 Sep;67(9):635-636. doi: 10.1007/s00101-018-0487-5.

本文引用的文献

1
Recognizing and resolving ABO discrepancies.识别和解决ABO血型不符问题。
Immunohematology. 2017 Jun;33(2):76-81.
2
SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents.2016年SHOT会议报告:输血的严重危害——人为因素仍是导致大多数输血相关事件的原因。
Transfus Med. 2016 Dec;26(6):401-405. doi: 10.1111/tme.12380.
3
The H blood group system.H血型系统。
Immunohematology. 2016 Sep;32(3):112-118.
4
The Challenges of Daratumumab in Transfusion Medicine.达雷妥尤单抗在输血医学中的挑战
Lab Med. 2017 Feb;48(1):6-9. doi: 10.1093/labmed/lmw055. Epub 2016 Oct 28.
5
Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.红细胞同种免疫与抗原暴露及其免疫原性的关系:一项队列研究。
Lancet Haematol. 2016 Jun;3(6):e284-92. doi: 10.1016/S2352-3026(16)30019-9. Epub 2016 May 9.
6
Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.ABO血型不相容的祖细胞移植的输血支持
Transfus Med Hemother. 2016 Jan;43(1):13-8. doi: 10.1159/000441612. Epub 2015 Oct 29.
7
When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy.当输血医学因单克隆抗体治疗的干扰而变得复杂时。
Transfusion. 2015 Jun;55(6 Pt 2):1555-62. doi: 10.1111/trf.13150. Epub 2015 May 18.
8
Resolving the daratumumab interference with blood compatibility testing.解决达雷妥尤单抗对血液相容性检测的干扰问题。
Transfusion. 2015 Jun;55(6 Pt 2):1545-54. doi: 10.1111/trf.13069. Epub 2015 Mar 12.
9
The direct antiglobulin test: a critical step in the evaluation of hemolysis.直接抗球蛋白试验:溶血评估中的关键步骤。
Am J Hematol. 2012 Jul;87(7):707-9. doi: 10.1002/ajh.23218. Epub 2012 May 6.
10
Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation.ABO血型不相合造血干细胞移植中的输血建议。
Transfusion. 2012 Feb;52(2):456-8. doi: 10.1111/j.1537-2995.2011.03465.x.